MedPath

CHLORDIAZEPOXIDE

CHLORDIAZEPOXIDE

Approved
DIN Number

00522996

Drug Class

Human

Market Date

Dec 31, 1981

Company
HC

aa pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00522996
AIG Number0100613002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA02 CHLORDIAZEPOXIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

CHLORDIAZEPOXIDE HYDROCHLORIDEActive
Strength: 25 MG
Monograph: CHLORDIAZEPOXIDE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.